The European Medicines Agency and Family Doctors

The European Medicines Agency and Family Doctors

N/A.

Bibliographic Details
Main Author:	Mary McCarthy
Format:	Article
Language:	English
Published:	Ordem dos Médicos 2018-08-01
Series:	Acta Médica Portuguesa
Subjects:	Drug Approval European Union Government Agencies Physicians, Family
Online Access:	https://actamedicaportuguesa.com/revista/index.php/amp/article/view/11021

Similar Items

Drug approval processes: A case study of rivaroxaban
by: Sally A Arif, et al.
Published: (2013-01-01)

ON THE FORMULATION OF THE EUROPEAN UNION AGENCY FOR FUNDAMENTAL RIGHTS
by: Petar Bačić
Published: (2006-01-01)

Drugs and Devices
by: Gail A. Van Norman, MD
Published: (2016-08-01)

Making Sense of the ‘Agency Programme’ in post-Lisbon Europe: Mapping European Agencies
by: Helena Margaretha Ekelund
Published: (2012-07-01)

THE EXPANSION OF EUROPEAN BUREAUCRACY
by: Ioan Popescu
Published: (2011-09-01)

Expertise and Power: Agencies Operating in Complex Environments
by: Anthony R. Zito
Published: (2015-03-01)

Differentiating Agency Independence: Perceptions from Inside the European Medicines Agency
by: Levan Makhashvili, et al.
Published: (2013-01-01)

Differentiating Agency Independence: Perceptions from Inside the European Medicines Agency
by: Levan Makhashvili, et al.
Published: (2013-02-01)

Mechanism, Analysis and Evolution of Jurisprudence on the Judicial Protection of European Union Agencies
by: Dimitris Liakopoulos
Published: (2019-09-01)

Influence of European Market Dynamics on Biosimilars Market Share
by: Diogo Pires, et al.
Published: (2016-10-01)

Agencies’ Reputational Game in an Evolving Environment: Europol and the European Parliament
by: Agathe Piquet
Published: (2021-07-01)

Family Benefits In Member States Of The European Union: A Comparative Perspective
by: Stănescu Simona Maria, et al.
Published: (2015-06-01)

How to Achieve National Goals in the European Union? Small State Strategy in Internal Security Integration
by: Ramon Loik, et al.
Published: (2016-09-01)

Regulatory reliance to approve new medicinal products in Latin American and Caribbean countries
by: Carlos E. Durán, et al.
Published: (2021-04-01)

The European Medicines Agency Clinical Data Website Enables Insights Into Clinical Development Timelines And Strategy
by: Lehmann S, et al.
Published: (2019-10-01)

FDA and EMA Approvals of New Breast Cancer Drugs—A Comparative Regulatory Analysis
by: Chandra P. Leo, et al.
Published: (2020-02-01)

EU Agencies and the Energy Union: Providing Useful Information to the Commission?
by: Torbjørg Jevnaker, et al.
Published: (2019-03-01)

African Agency and EU-ACP Relations beyond the Cotonou Agreement
by: Stephen R Hurt
Published: (2020-06-01)

Pragmatic clinical trials in the context of regulation of medicines
by: Rolf Gedeborg, et al.
Published: (2019-01-01)

The European Environment Agency in International Relations - From a Passive Respondent to an Active Participant and Influencer in International Relations
by: Mäkelä, Kyösti
Published: (2020)

Family Doctor Leadership in African Primary Health Care
by: Shabir Moosa
Published: (2021-09-01)

Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications
by: Hye-Young Kwon, et al.
Published: (2018-09-01)

The European Semester: understanding an innovative governance model
Published: (2020)

Quaternary Prevention, an Answer of Family Doctors to Overmedicalization
by: Marc Jamoulle
Published: (2015-02-01)

The Iterative Development of Medicines Through the European Medicine Agency's Adaptive Pathway Approach
by: Giuseppe Nicotera, et al.
Published: (2019-06-01)

U.S. Food and Drug Administration: Review for the Emergency Physician of Approval Process and Limitations
by: Nadia Zuabi, et al.
Published: (2016-11-01)

Differences between the European and Eurasian Good Pharmacovigilance Practices
by: A. V. Matveev, et al.
Published: (2021-07-01)

Regions in the European Union: processes and paradigms
by: Lucia Alexandra Popartan, et al.
Published: (2012-09-01)

A Political and Macroeconomic Explanation of Public Support for European Integration
by: Carey, Sean D. (Sean Damien)
Published: (1997)

Drugs approved by CDSCO, India in 2015
by: K Parushuram Naik1 , V Sai Lakshmi2 , J Jyothirmai3
Published: (2016-04-01)

Assessing the Role of EU Agencies in the Enlargement Process: the Case of the European Aviation Safety Agency
by: Florin Coman-Kund
Published: (2012-12-01)

Is the EU a social union? :the function of common social policy for European integration
by: Zhang, Lu
Published: (2012)

Rent-seeking practices in the housing development approval process
by: Abdul-Aziz, A.-R, et al.
Published: (2021)

Improving Interactions Between Health Technology Assessment Bodies and Regulatory Agencies: A Systematic Review and Cross-Sectional Survey on Processes, Progress, Outcomes, and Challenges
by: Richard Ofori-Asenso, et al.
Published: (2020-10-01)

Legal and organizational specificities of the European Union's office for harmonization in the internal market
by: Ćemalović Uroš
Published: (2014-01-01)

GOVERNING ECONOMIC INTERESTS BY THE EUROPEAN COMMISSION
by: Anna Ząbkowicz
Published: (2015-01-01)

Reimbursement of Orphan Drugs in Europe in Relation to the Type of Authorization by the European Medicines Agency and the Decision Making Based on Health Technology Assessment
by: Krzysztof Piotr Malinowski, et al.
Published: (2018-11-01)

THE AGENCY FOR FUNDAMENTAL RIGHTS AND ITS ROLE WITHIN THE FRAMEWORK OF THE EUROPEAN UNION
by: Isabela, STANCEA, et al.
Published: (2014-11-01)

European Space Agency: an Overview of the Legal Frame
by: Inessa Kostenko
Published: (2019-03-01)

Medicines under additional monitoring in the European Union
by: Esther Salgueiro, et al.
Published: (2019-01-01)